Abstract
to provide a structured overview of education and training opportunities in health economics (HE)/pharmacoeconomics (PE)/health technology assessment (HTA) in the countries of ISPOR CEE Consortium. survey was carried out during November, 2018 - May, 2019 in the form of questionnaire that was sent to ISPOR CEE Chapters using Survey Monkey app. Questionnaire consists of 8 chapters and 36 questions about: general country information; education and training programmes on HE/PE/HTA; official methodological guidelines, journals and annual conferences dedicated to HE/PE/HTA. responses from Bosnia and Herzegovina (BA), Bulgaria (BG), Hungary (HU), Poland (PL), Romania (RO), Russia (RU), Slovak Republic (SK), Turkey (TR), Ukraine (UA) were analyzed. It was revealed that these countries have quite similar national health expenditure in % GDP. The all countries, except of RO, have legislative act(s) at the national level regulating HE/outcomes research/HTA utilization to inform decision-making for health. BA, BG, RO, UA provide HE/PE courses at undergraduate education level; BA, BG, HU, PL, TK, UA - at graduate, and BG, HU, PL, SK, UA - at postgraduate levels. All participants do not have HTA courses at undergraduate level; BG, HU, PL, UA provide them at graduate and postgraduate levels. Additionally to these countries, BA and SK give HTA courses to students in master's programmes. Only in UA are provided mini-HTA courses. Courses are mostly given in the national languages, there are also certain courses given in English. Apart from BA and RO, the countries have official methodological guidelines on HE/PE/HTA. Most of countries publish peer-reviewed journals on HE/PE/HTA and the all countries conduct annual conferences dedicated to the studied topic. The obtained results showed that most of CEE Consortium countries participated in the survey have education systems on HE/PE/HTA. Development of core education programmes on HE/PE/HTA in CEE for training of the decision-makers is highly perspective.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
